Combining panobinostat with ruxotinib to treat cancer is like a kind of diffuse tumor

摘要

It refers to a drug synthesis, including: (a) a JAK inhibitor, which is (R) - 3 - (4 - (7h pirrolo [2, 3-d] pirimidin-4-il) - 1h-pirazol-1-il) - 3-cyclopentanediol (ruxotinib), 10-20 mg / day; (b) A n-octyl-3 - [2 - (2 - (2-methyl-1-indoli-3-yi) - ethyl] - amino methyl] phenyl-2e-2-phenyl (panobnostat) taken every two weeks in 10 to 30 mg, three times a week; in this case, the compound contained is a separate or single formulation. This combination is useful in the treatment of chronic leukemia, veradomia, and basic thromboses,Primary fibrosis, chronic neutrophilic leukemia